• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD ACCESS SYSTEMS GROSHONG PORT S/L CHINA ONLY; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD ACCESS SYSTEMS GROSHONG PORT S/L CHINA ONLY; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 0603870C
Device Problems Break (1069); Fracture (1260); Material Separation (1562)
Patient Problem Injury (2348)
Event Date 10/29/2019
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was not provided, a manufacturing review could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.
 
Event Description
It was reported that approximately two years and one month post port placement in the left chest wall via left internal jugular vein, a chest radiography allegedly demonstrated a catheter rupture.Reportedly, the catheter remained in the atrium and ventricle.It was further reported that the port and catheter were removed under digital subtraction angiography (dsa).The patient remained in the hospital for one week.There were no further reported complications.
 
Manufacturer Narrative
H10: manufacturing review: a lot history record review could not be completed as the lot number was not provided.Investigation summary: one mri low-profile port with groshong catheter in two segments and cathlock was returned for evaluation.Functional, gross visual and microscopic visual evaluations were performed.A photo and a radiograph image were provided and reviewed.The investigation is confirmed for complete catheter break and catheter embolism, as the groshong catheter was returned in two segments.A complete circumferential break was identified near the 15 cm depth marker or approximately 10.4 cm from the distal end of the cathlock.Two short longitudinally aligned splits were identified extending from either side of the complete break, and one short longitudinally aligned split was observed just proximal to the distal end of the proximal catheter fragment.The cross-sectional surfaces of both break ends had regions of granularity with sharp edges and smooth regions with rounded edges.The lumen shape at both break ends appeared to have a flattened elliptical shape.Mushrooming of the catheter was observed at the port-catheter connection on the proximal catheter fragment.These observations are consistent with fracture, material separation, naturally worn and deformation due to compressive stress issues.Per the medical image review, there is embolized catheter tubing overlying the heart from the break at the internal jugular vein insertion site.This is consistent with a device migration issue.The definitive root cause could not be determined based upon available information.Labeling review: the cause of the event in question is unknown, and so the applicability of any particular portion of the ifu or other labeling is unknown.However, a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the ifu instructs on port implantation, catheter insertion, tunneling the catheter and connecting the catheter to the port.Therefore, the product labeling will be considered adequate.H10: g4, h6(device code - 2988, 2889, 1395/4003) h11: d10, h3, h6(method, results, conclusion) h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that approximately two years and one month post port placement in the left chest wall via left internal jugular vein, a chest radiography allegedly demonstrated a catheter rupture.Reportedly, the catheter remained in the atrium and ventricle.It was further reported that the port and catheter were removed under digital subtraction angiography (dsa).The patient remained in the hospital for one week.There were no further reported complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GROSHONG PORT S/L CHINA ONLY
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
BARD ACCESS SYSTEMS
605 n. 5600 w.
salt lake city UT 84116
MDR Report Key9516528
MDR Text Key172597948
Report Number3006260740-2019-04006
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741111280
UDI-Public(01)00801741111280
Combination Product (y/n)N
PMA/PMN Number
K081311
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/24/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number0603870C
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/03/2020
Date Manufacturer Received06/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
Patient Weight55
-
-